US 2021 Consumer Health Fraud Headaches Include Securities Scam By ‘Fast-Acting Aspirin’ Firm

COVID-19 Remains Common In Unlawful Sales, Claims Investigated By DoJ, FDA

FDA worked on investigations with US Attorneys’ offices and other federal agencies of unlawful sales of supplements promoted to prevent or treat COVID-19 as well as other diseases and health conditions and of prescription drugs offered OTC for muscle growth or sexual enhancement.

• Source: Alamy

COVID-19 fraud was common among federal prosecutors’ consumer health-related investigations again in 2021, but their work also included charges linked to a securities scam for a firm claiming to develop a fast-acting aspirin and the revocation of citizenship for a man and woman in Georgia.

The Department of Justice identified the Food and Drug Administration as assisting in numerous investigations around the US during the year that led to charges, typically through indictments by federal

In addition to persons or businesses selling or importing unapproved Rx drugs and medical devices or filing fraudulent claims for federal or state insurance program payments for products and services, the FDA worked on investigations with US Attorneys’ offices and other federal agencies of unlawful sales of dietary supplements promoted to prevent or treat COVID-19 as well as

More from Compliance

More from Policy & Regulation